The two sides aim to pursue joint investment, research, scientific publications, and the development of advanced biomedical products, leveraging the strengths of both research institutes and the two ...
On 5 August, the US Food and Drug Administration (FDA) granted approval to Moderna’s mRNA-based flu vaccine, mFLUSIVA, for adults aged 50–64, and accelerated approval for adults 65 and older. Moderna ...
Spider-Man Brand New Day science earns expert review from a Cambridge biochemist who confirms the film named siRNA correctly ...
The Chosun Ilbo on MSN
CRISPR anticancer tech targets cancer mutations, spares healthy cells
A domestic research team is developing an anticancer technology that attacks DNA mutations found only in cancer cells while ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results